Antiangiogenic Therapy for Metastatic Breast Cancer : Current Status and Future DirectionsCHAN, Arlene.Drugs (Basel). 2009, Vol 69, Num 2, pp 167-181, issn 0012-6667, 15 p.Article

Capecitabine and vinorelbine in metastatic breast cancerCHAN, Arlene; VERRILL, Mark.European journal of cancer (1990). 2009, Vol 45, Num 13, pp 2253-2265, issn 0959-8049, 13 p.Article

Adjuvant Trastuzumab in HER2-Positive Breast CancerSLAMON, Dennis; EIERMANN, Wolfgang; PINTER, Tamas et al.The New England journal of medicine. 2011, Vol 365, Num 14, pp 1273-1283, issn 0028-4793, 11 p.Article

Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast CancerMILES, David W; CHAN, Arlene; HARBECK, Nadia et al.Journal of clinical oncology. 2010, Vol 28, Num 20, pp 3239-3247, issn 0732-183X, 9 p.Article

Prevalence of Excessive Tearing in Women With Early Breast Cancer Receiving Adjuvant Docetaxel-Based ChemotherapyCHAN, Arlene; SU, Charles; DE BOER, Richard H et al.Journal of clinical oncology. 2013, Vol 31, Num 17, pp 2123-2127, issn 0732-183X, 5 p.Article

Randomized Phase II Study of the Anti―Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast CancerBASELGA, José; GOMEZ, Patricia; GOEMINNE, Jean-Charles et al.Journal of clinical oncology. 2013, Vol 31, Num 20, pp 2586-2592, issn 0732-183X, 7 p.Article

First-Line Treatment of Advanced Breast Cancer With Sunitinib in Combination With Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III StudyBERGH, Jonas; BONDARENKO, Igor M; CHAN, Arlene et al.Journal of clinical oncology. 2012, Vol 30, Num 9, pp 921-929, issn 0732-183X, 9 p.Article

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab : updated efficacy and biomarker analysesCAMERON, David; CASEY, Michelle; CHAN, Arlene et al.Breast cancer research and treatment. 2008, Vol 112, Num 3, pp 533-543, issn 0167-6806, 11 p.Article

Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase II studyHYAMS, David M; CHAN, Arlene; BROWN, Kathryn et al.Investigational new drugs. 2013, Vol 31, Num 5, pp 1345-1354, issn 0167-6997, 10 p.Article

Reporting of myelotoxicity associated with emerging regimens for the treatment of selected solid tumorsCHAN, Arlene; VERMA, Shailendra; LOIBL, Sibylle et al.Critical reviews in oncology/hematology. 2012, Vol 81, Num 2, pp 136-150, issn 1040-8428, 15 p.Article

A pilot study of trimodality breast imaging surveillance in young women at high risk of breast cancer in Western AustraliaSAUNDERS, Christobel M; PETERS, Gudrun; ANDERSON, James et al.Medical journal of Australia. 2009, Vol 191, Num 6, pp 330-333, issn 0025-729X, 4 p.Article

Accuracy of the Oncology patients Information system in a Regional Cancer CentreYAU, Jonathan C; CHAN, Arlene; EAPEN, Tamina et al.Oncology reports. 2002, Vol 9, Num 1, pp 167-169, issn 1021-335XArticle

AVEREL: A Randomized Phase III Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER2-Positive Locally Recurrent/Metastatic Breast CancerGIANNI, Luca; ROMIEU, Gilles H; CHAN, Stephen et al.Journal of clinical oncology. 2013, Vol 31, Num 14, pp 1719-1725, issn 0732-183X, 7 p.Article

Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast CancerWOLFF, Antonio C; LAZAR, Ann A; CHAN, Arlene et al.Journal of clinical oncology. 2013, Vol 31, Num 2, pp 195-202, issn 0732-183X, 8 p.Article

Phase III Study of Doxorubicin/Cyclophosphamide With Concomitant Versus Sequential Docetaxel As Adjuvant Treatment in Patients With Human Epidermal Growth Factor Receptor 2-Normal, Node-Positive Breast Cancer: BCIRG-005 TrialEIERMANN, Wolfgang; PIENKOWSKI, Tadeusz; PRESS, Michael et al.Journal of clinical oncology. 2011, Vol 29, Num 29, pp 3877-3884, issn 0732-183X, 8 p.Article

Lapatinib plus capecitabine for HER2-positive advanced breast cancerGEYER, Charles E; FORSTER, John; SKARLOS, Dimosthenis et al.The New England journal of medicine. 2006, Vol 355, Num 26, pp 2733-2743, issn 0028-4793, 11 p.Article